跳至主要内容
临床试验/ITMCTR2026001724
ITMCTR2026001724进行中(未招募)Unknown

Efficacy and safety of Futong Feian Decoction in preventing stroke-associated pneumonia in patients with acute ischemic stroke (the heat-phlegm and sthenic-fu syndrome): a randomized controlled trial.

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点开始时间: 2026年7月15日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 85(—)
性别
All

入选标准

  • 1.Age between 18 and 85 years (inclusive);
  • 2.Meet the Western medicine clinical diagnostic criteria for acute ischemic stroke;
  • 3.Meet the traditional Chinese medicine diagnostic criteria for stroke and be diagnosed with the heat-phlegm and sthenic-fu syndrome;
  • 4.Admitted to hospital within 24 hours of acute symptom onset;
  • 5.Provide informed consent and sign the informed consent form.

排除标准

  • 1.Presence of diseases requiring differentiation from stroke-associated pneumonia, such as pulmonary tuberculosis, etc.;
  • 2.History of pre-hospital infection or recent history of antibiotic use;
  • 3.Patients requiring mechanical ventilation;
  • 4.Pregnant or lactating women;
  • 5.Allergy to drugs of the same class or any ingredient contained in the investigational drug;
  • 6.Patients with abnormal cardiac, hepatic, or renal function, hematologic diseases, malignant tumors, or immunodeficiency.

研究者

相似试验